Astrana Health (NASDAQ:ASTH) Sets New 52-Week High – Here’s What Happened

Shares of Astrana Health, Inc. (NASDAQ:ASTH) hit a new 52-week high on Monday . The company traded as high as $44.99 and last traded at $44.5560, with a volume of 4113 shares trading hands. The stock had previously closed at $44.51.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. BTIG Research reaffirmed a “buy” rating and set a $50.00 target price on shares of Astrana Health in a research note on Tuesday, June 2nd. Barclays raised shares of Astrana Health from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $37.00 to $50.00 in a research report on Tuesday, May 26th. Truist Financial boosted their price target on shares of Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research note on Thursday, May 14th. TD Cowen upped their price objective on Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Finally, Needham & Company LLC increased their price objective on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Seven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $45.00.

Astrana Health Stock Up 3.1%

The business’s 50 day moving average is $38.05 and its 200-day moving average is $29.14. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.35. The company has a market cap of $2.59 billion, a PE ratio of 76.08 and a beta of 1.00.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.74 EPS for the quarter, topping the consensus estimate of $0.29 by $0.45. The company had revenue of $965.10 million during the quarter, compared to analysts’ expectations of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The firm’s revenue was up 55.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.42 EPS. As a group, analysts predict that Astrana Health, Inc. will post 1.25 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ASTH. Signaturefd LLC boosted its holdings in shares of Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after buying an additional 388 shares in the last quarter. GAMMA Investing LLC lifted its position in Astrana Health by 144.7% in the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after acquiring an additional 871 shares during the last quarter. Strs Ohio purchased a new stake in Astrana Health in the fourth quarter valued at $40,000. Tower Research Capital LLC TRC lifted its position in Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after acquiring an additional 3,517 shares during the last quarter. Finally, State of Wyoming acquired a new position in Astrana Health in the second quarter valued at $132,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.